Search
+

    Covid-19: India to start late stage clinical trials of Oxford vaccine

    Copy URL
    Embed

    The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials.

    3859views
    Have something to say? Post your comment
    The Economic Times